News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Abcam plc (ABC.L) Buys Epitomics, Inc. for $170 Million



3/7/2012 7:47:35 AM

March 6, 2012 -- Abcam, a UK maker of protein research tools, will pay $170 million to buy Epitomics, a San Francisco-area company that has developed humanized rabbit monoclonal antibodies for research purposes. Epitomics has an antibody manufacturing facility in Hangzhou that employs more than 200. The company is led by Guo-Liang Yu, PhD, President, CEO and Chairman of the Board. Dr. Yu received an undergraduate degree from Fudan University in Shanghai before immigrating to the US. He did his graduate work at UC Berkeley and Harvard Medical School. More details....

Stock Symbol: (AIM: ABC)


Read at ChinaBio Today
Read at News Release
Read at Reuters


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES